We have assembled this information to answer frequently asked questions about Merkel cell carcinoma (MCC). Since MCC is an uncommon malignancy, few patients are familiar with the disease and few doctors are familiar with its treatment. Easy access to understandable information is often difficult to obtain. In this resource, we have combined our review of the best available literature and our experience caring for over 800 patients with MCC at the Dana-Farber Cancer Institute and the Seattle Cancer Care Alliance. This information is designed to facilitate key therapeutic decisions that need to be made within weeks to months of initial diagnosis of MCC. Please discuss any questions that you may have with your doctor and MCC specialist.
The authoritative source on Merkel cell carcinoma.
November 30, 2017